GENE ONLINE|News &
Opinion
Blog

Actemra
COVID-19 IL-6
WHO Recommends the Use of Sanofi’s and Roche’s Rheumatoid Arthritis Drugs to Cut COVID-19 Deaths
2021-07-12
Innovative Diagnostics, AI, Blockchain and Telemedicine Boosts COVID-19 Fight
2020-07-26Partner
COVID-19 Anti-COVID Drug
Potential Repurposed Drugs Currently in Evaluation for COVID-19
2020-05-01
COVID-19 Japan
Chugai Initiates Actemra’s Phase 3 COVID-19 Trials in Japan
2020-04-11
COVID-19 PARP Inhibitor
Genentech’s Actemra gets FDA approval to begin COVID-19 Trials in April
2020-03-25
LATEST
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
Rice University Engineers Develop Miniature Brain Stimulator for Safer and Less-invasive Neuromodulation
2024-04-17
Breakthrough Screening Platform to Assess SARS-CoV-2 Mutations and Potential Treatments
2024-04-16
READ MORE
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top